GL1X · GenesisL1 explorer

Research workbench

X-ray crystallographic structure of ctx-M-9 beta-lactamase complexed with nafcinin-like boronic acid inhibitor

Analyse X-ray crystallographic structure of ctx-M-9 beta-lactamase complexed with… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
1YMS
Type
protein
Length
524 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Beta-lactamase ctx-M-9
EC
3.5.2.6
UniProt
Q9L5C8
Ligands
NBF
Pockets
2 · best druggability 0.38

Structure

x-ray diffraction · 2 distinct chains · 43% helix, 19% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ABeta-lactamase ctx-M-9 (EC 3.5.2.6)protein26343% helix, 19% strandQ9L5C8
BBeta-lactamase ctx-M-9 (EC 3.5.2.6)protein26143% helix, 19% strandQ9L5C8

Ligands and binding sites

  • NBF · [(2-ethoxy-1-naphthoyl)amino]methylboronic acid · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1960.380.7626NBF
2670.300.7522NBF

Interfaces

1 interface between chains.

  • A–B · 109 Ų buried · 1 hydrogen bond · protein-protein

Modifications

Observed in the structure: 2 covalent (covalent ligand).

Compared structures

  • 1YMS · X-ray crystallographic structure of CTX-M-9 beta-lactamase complexed with nafcinin-like… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.